InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Pine Michael Craig, Directeur du Développement Corporatif et Stratégique. Insider active across 1 company, notably EyePoint Pharmaceuticals, Inc.. In total, 4 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €11k. Activity tracked since 14 March 2022. The latest transaction was disclosed on 6 January 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Pine Michael Craig is the Chief Corp Dev.&Strat. Officer of EyePoint Pharmaceuticals, Inc. He is responsible for the development strategy and growth initiatives of the company. His expertise is crucial for expansion and innovation.